May Daher
May Daher, MD is a physician scientist, Assistant Professor in the Stem Cell Transplant and Cellular Therapy Department at MD Anderson Cancer Center. May is also the Associate Director of
Amit K. Verma
Amit K. Verma, M.B.B.S is a Professor in the Department of Oncology (Medical Oncology), Department of Medicine (Oncology & Hematology) and Department of Developmental & Molecular Biology, Director of Division of Hemato-Oncology
Arul M. Chinnaiyan
Arul M. Chinnaiyan, M.D., Ph.D. is the Director of the Michigan Center for Translational Pathology, the S.P. Hicks Endowed Professor of Pathology and Urology at the University of Michigan, and
Dr. Kumar Srinivasan
Kumar Srinivasan, Ph.D., MBA, in his most recent role served as executive vice president and chief business officer at Turning Point Therapeutics with responsibility for corporate strategy and business development,
Dr. Shubhada Chiplunkar
Prof Shubhada Chiplunkar Former Director of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai and the Head of Cancer Immunology and Immunotherapy
Hariharnath Buggana
Hariharnath Buggana is the Managing Director of InvAscent India – a private equity firm focused on Indian healthcare, pharma, and medtech industries. Prior to this, Hari was a consultant with
Dr. Bruce Carter
Dr. Bruce LA Carter is an independent member of the board at Dr. Reddy’s for the past seven years. He started his long and illustrious career in the biopharma industry
M V Ramana
M V Ramana is Chief Executive Officer, Branded Markets (India and Emerging Markets) and leads innovation for Dr. Reddy’s. In this role, he leads a multicultural team in 45 countries.
Parag Agarwal
Parag Agarwal is the Chief Financial Officer of Dr. Reddy’s Laboratories Limited. He joined Dr. Reddy’s from London-based Reckitt Benckiser PLC, where he was the CFO for Health. In a